Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00337662
What this trial is testing

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Eli Lilly and Company 628
Post-approval studies (Phase 4)Study completedNCT02435654
What this trial is testing

5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia

Who this might be right for
Early-onset Schizophrenia
Kunming Medical University 128
Post-approval studies (Phase 4)Looking for participantsNCT07109245
What this trial is testing

Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?

Who this might be right for
Brain Insulin SensitivityHealthy ControlsCognition
Centre for Addiction and Mental Health 35
Not applicableLooking for participantsNCT06049953
What this trial is testing

Maternal And Infant Antipsychotic Study

Who this might be right for
AntipsychoticsPregnancy
Icahn School of Medicine at Mount Sinai 74
Post-approval studies (Phase 4)Study completedNCT00333177
What this trial is testing

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 92
Testing effectiveness (Phase 2)Study completedNCT00709202
What this trial is testing

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+5 more
Nathan Kline Institute for Psychiatric Research 48
Not applicableUnknownNCT02880995
What this trial is testing

[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis

Who this might be right for
Schizophrenia
Seoul National University Hospital 62
Early research (Phase 1)Study completedNCT00791401
What this trial is testing

The Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

Who this might be right for
SchizophreniaRenal Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Not applicableStudy completedNCT01491412
What this trial is testing

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

Who this might be right for
Acute Psychotic EpisodeSchizophrenia
AstraZeneca 503
Early research (Phase 1)Study completedNCT01908296
What this trial is testing

Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers

Who this might be right for
HealthyPharmacokinetics of Quetiapine
Astellas Pharma Inc 24
Not applicableStudy completedNCT00169988
What this trial is testing

Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

Who this might be right for
Prodromal SchizophreniaPsychotic Disorders
Northwell Health 8
Not applicableStudy completedNCT02295462
What this trial is testing

Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial

Who this might be right for
Dementia
Martin-Luther-Universität Halle-Wittenberg 1,158
Not applicableUnknownNCT03062033
What this trial is testing

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 70
Not applicableStudy completedNCT05633108
What this trial is testing

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Who this might be right for
Psychotic Disorders
Eisai Co., Ltd. 579,728
Large-scale testing (Phase 3)Study completedNCT01448720
What this trial is testing

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

Who this might be right for
Schizophrenia
Janssen-Cilag Farmaceutica Ltda. 142
Testing effectiveness (Phase 2)Study completedNCT00215150
What this trial is testing

Geodon for the Treatment of Refractory Social Anxiety Disorder

Who this might be right for
Social Anxiety Disorder
Duke University 51
Post-approval studies (Phase 4)Study completedNCT00864825
What this trial is testing

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheba Medical Center 248
Large-scale testing (Phase 3)Study completedNCT00111189
What this trial is testing

The Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 414
Early research (Phase 1)Study completedNCT01231074
What this trial is testing

Reducing Antipsychotic-Induced Weight Gain in Children With Metformin

Who this might be right for
ObesityWeight GainPsychotropic Induced Weight Gain
Nationwide Children's Hospital 96
Not applicableStudy completedNCT01342120
What this trial is testing

PHARMO Institute Seroquel Safety Study

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Disorder+1 more
AstraZeneca 18,325
Next Page